Alphabet results take S&P 500, NASDAQ to record highs
Digest more
Wall Street’s relentless rally this summer has driven stock valuations close to record levels, prompting warnings that “euphoric” markets are entering bubble territory.
Besides Wall Street, Arista Networks is growing increasingly popular with customers. The company's industry-leading switches are in high demand as data centers look to shore up their computing infrastructure to support AI computing. And demand for the company's networking solutions seems unlikely to taper off anytime soon.
Edwards Lifesciences rose 5.5% after likewise topping Wall Street’s expectations for profit in the latest quarter. It said it saw strength across all its product groups, and it expects profit for the full year to come in at the high end of the forecasted range it had given earlier.
Just because you missed out on the huge rally in the S&P 500 since April 8 doesn't mean it's necessarily a bad time to put money to work.
To be considered for admission to the S&P 500, a company must meet the following criteria:
Palantir (NASDAQ:PLTR) is a colossal winner that’s just found a way to keep winning in 2025. With shares up more than 37% in the past three months and over 105% year to date, questions linger as to whether the AI software titan is like an Nvidia (NASDAQ:NVDA),
NEW YORK (AP) — Wall Street is hanging near its records on Thursday, but the calm surface of the U.S. stock market is hiding some roiling moves underneath. Alphabet is rallying, and Tesla is sinking sharply following a jumble of profit reports from big U.S. companies.
In short, history says the stock market is about to soar, and most Wall Street analysts who follow The Trade Desk ( TTD 0.48%) and Pure Storage ( PSTG -0.59%) have buy ratings on the stocks. Among 42 analysts, The Trade Desk has a median target price of $90 per share. That implies 10% upside from its current share price of $82.
Arm shares rose Monday as analysts at Wells Fargo raised their price target for the chip designer’s stock ahead of its quarterly earnings due next week.
Edwards Lifesciences rose 4.3% after likewise topping Wall Street’s expectations for profit in the latest quarter. It said it saw strength across all its product groups, and it expects profit for the full year to come in at the high end of the forecasted range it had given earlier.